ArticleCancer immunology, immunotherapy : CII2023

Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment.

Maria Del Mar Maldonado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.